Related Experiment Video
Updated: Aug 30, 2025
04:56
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
832
Coronavirus Disease 2019-Associated Coagulopathy
Jun-Won Seo1, Da-Young Kim1, Nara Yun1
1Division of Infectious Disease, Department of Internal Medicine, College of Medicine, Chosun University, Gwangju 61453, Korea.
Microorganisms
|August 26, 2022
Summary
COVID-19-associated coagulopathy involves blood clot risks. Early use of prophylactic anticoagulation in severe COVID-19 cases improves survival without increasing bleeding risks.
Area of Science:
- Hematology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) can lead to coagulopathy, a condition involving blood clotting issues.
- This coagulopathy presents as thrombosis, potentially with hemorrhage, affecting various anatomical sites.
- Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, is frequently observed in severe COVID-19 patients.
Purpose of the Study:
- To summarize the understanding of COVID-19-associated coagulopathy.
- To highlight diagnostic markers and treatment strategies.
- To emphasize the role of prophylactic anticoagulation in severe cases.
Main Methods:
- Review of clinical manifestations and laboratory findings associated with COVID-19-associated coagulopathy.
- Analysis of current treatment guidelines for anticoagulation.
- Evaluation of the impact of prophylactic anticoagulation on patient outcomes.
Main Results:
- COVID-19-associated coagulopathy is characterized by thrombosis and can manifest with hemorrhage.
- Diagnostic tools include D-dimer levels and platelet counts.
- Anticoagulation, including direct oral anticoagulants and low-molecular-weight heparin, is a key treatment.
Conclusions:
- Prophylactic anticoagulation is crucial for preventing coagulopathy in severe COVID-19.
- Early initiation of prophylactic anticoagulation improves survival rates.
- This approach can be implemented without a significant increase in serious bleeding events.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.9K
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
607
Related Concept Videos
01:06Coagulation
357
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
357
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
863
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
863
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
02:45Blood Transfusion and Agglutination
11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
29
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
29